Immuneering (IMRX) Gains from Investment Securities (2020 - 2025)
Immuneering (IMRX) recorded quarterly Gains from Investment Securities of -$2093.0 in Q4 2025, up 61.73% quarter-over-quarter from -$5469.0 in Q4 2024, and up 61.73% on a YoY basis from -$1294.1 in Q4 2024.
Immuneering (IMRX) Gains from Investment Securities (2020 - 2025) Analysis & Trends
Immuneering's Gains from Investment Securities history runs 6 years deep, the most recent figure standing at -$2093.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities rose 61.73% year-over-year to -$2093.0; the TTM figure through Dec 2025 stood at -$8877.0 (down 30.85% YoY), while the FY2025 annual figure was -$2093.0, up 69.15% from the prior year.
- Gains from Investment Securities was -$2093.0 for Q4 2025 at Immuneering, up from -$5469.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $3.8 million in Q2 2022 to a low of -$5469.0 in Q4 2024.
- Historically, Gains from Investment Securities has averaged $796726.2 across 5 years, with a median of -$741.5 in 2023.
- The sharpest annual moves came in 2021 and 2024: Gains from Investment Securities soared 833.83% in 2021, then sank 122.68% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $1.5 million in 2021, then sank by 100.36% to -$5170.0 in 2022, then soared by 52.5% to -$2456.0 in 2023, then tumbled by 122.68% to -$5469.0 in 2024, then soared by 61.73% to -$2093.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$2093.0 (Q4 2025), -$5469.0 (Q4 2024), and -$1315.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,093.00 |
| Dec 31, 2025 | -2,093.00 |
| Dec 31, 2024 | -5,469.00 |
| Dec 31, 2024 | -5,469.00 |
| Sep 30, 2024 | -1,315.00 |
| Sep 30, 2024 | -1,315.00 |
| Dec 31, 2023 | -2,456.00 |
| Dec 31, 2023 | -2,456.00 |
| Jun 30, 2023 | -817.00 |
| Jun 30, 2023 | -817.00 |
| Mar 31, 2023 | -666.00 |
| Mar 31, 2023 | -666.00 |
| Dec 31, 2022 | -5,170.00 |
| Dec 31, 2022 | -5,170.00 |
| Sep 30, 2022 | 276,795.00 |
| Sep 30, 2022 | 276,795.00 |
| Jun 30, 2022 | 3.83 Mn |
| Jun 30, 2022 | 3.83 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Dec 31, 2021 | 1.45 Mn |